Milvexian Intermediate: High-Purity CAS 1802431-24-8 Manufacturer & Supplier for Pharmaceutical Synthesis

Discover the critical role of Milvexian Intermediate (CAS 1802431-24-8) in the advanced synthesis of Milvexian, a groundbreaking oral Factor XIa inhibitor. As a premier manufacturer and supplier in China, we provide researchers and pharmaceutical companies with exceptionally high-purity intermediates essential for cardiovascular drug development. Secure your supply chain with a trusted source for pharmaceutical raw materials.

Get a Quote & Sample

Advantages of Sourcing Milvexian Intermediate from Us

Uncompromising Purity and Quality

Our Milvexian Intermediate (CAS 1802431-24-8) boasts a purity exceeding 98%, manufactured under strict GMP and ISO guidelines. This ensures consistent performance and reliability in your complex pharmaceutical synthesis processes. Rely on us as your primary manufacturer.

Reliable Supply and Competitive Pricing

As a direct supplier from China, we offer competitive prices for Milvexian Intermediate. Our robust production capacity and streamlined logistics ensure a stable and timely supply, meeting the demands of your projects. Enquire about bulk purchase options.

Expertise in Pharmaceutical Intermediates

Leverage our deep understanding of pharmaceutical synthesis and regulatory requirements. We are committed to supporting your research and development efforts with high-quality intermediates, making us your ideal partner to buy from.

Key Applications and Research Focus

Milvexian Synthesis

This intermediate is the foundational building block for Milvexian, a novel oral Factor XIa inhibitor being developed for anticoagulation therapy. Essential for researchers synthesizing the active pharmaceutical ingredient (API).

Cardiovascular Drug Development

Crucial for R&D in the cardiovascular field, supporting the creation of advanced antithrombotic agents aimed at improving patient outcomes and safety profiles compared to existing treatments.

Scientific Research

Utilized in academic and industrial laboratories for studies related to coagulation, thrombosis, and the development of novel therapeutic strategies targeting Factor XIa.

API Manufacturing

A key raw material for API manufacturers, ensuring the consistent production of high-quality Milvexian for clinical trials and commercial supply. Contact us for a quote.